Behandling av cisplatinresistent lungcancer : Induktionsstudie av Gb3-uttryck hos lungcancerceller

Behandling av cisplatinresistent lungcancer : Induktionsstudie av Gb3-uttryck hos lungcancerceller

Bibliographic Details
Main Author:	Weinz, Fanny
Format:	Others
Language:	Swedish
Published:	Umeå universitet, Biomedicinsk laboratorievetenskap 2012
Subjects:	Icke-småcellig lungcancer Cisplatin Globotriaosylceramid (Gb3) Multidrogresistens Verotoxin-1.
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-57975

Similar Items

En kartläggning av symtomkluster hos patienter med lungcancer : En litteraturstudie
by: Andersson, Sofia, et al.
Published: (2015)

Vuxna patienters upplevelser av att vara drabbade av lungcancer.
by: Ekström, Eva, et al.
Published: (2013)

Personers upplevelser av att leva med lungcancer
by: Wanglin, Anna, et al.
Published: (2015)

Patienters upplevelser i samband med lungcancer
by: Andersson, Isabell, et al.
Published: (2012)

Distribution of Gb3 Immunoreactivity in the Mouse Central Nervous System
by: Tom Obrig, et al.
Published: (2010-08-01)

Patienters erfarenheter av att leva med lungcancer : En kvalitativ litteraturstudie
by: Bengtsson, Zarah, et al.
Published: (2019)

Investigating the Anti-viral Property of Verotoxin and its Receptor Gb3 in Preventing Primary HIV-1 Infection
by: Shi, Peilin
Published: (2011)

Investigating the Anti-viral Property of Verotoxin and its Receptor Gb3 in Preventing Primary HIV-1 Infection
by: Shi, Peilin
Published: (2011)

Patienters upplevelser av lungcancer
by: Lidenmark, Ida, et al.
Published: (2007)

Personers upplevelser av att leva med lungcancer : en litteraturstudie
by: Eriksson, Ida, et al.
Published: (2020)

Dömd på förhand : Upplevelser av stigamtisering vid lungcancer
by: Nilsson, Emma, et al.
Published: (2015)

Patientens upplevelse av livskvalitet vid lungcancer : En litteraturstudie
by: Al-nasir, Banin, et al.
Published: (2018)

Upplevelser av att leva med lungcancer : En litteraturbaserad studie
by: Bergström, Evelyn, et al.
Published: (2011)

Att leva med lungcancer : En allmän litteraturöversikt
by: Eriksson Hörberg, Therese, et al.
Published: (2021)

Kommunikation mellan vårdpersonal och patient med lungcancer : En litteraturstudie
by: Persson, Marcus, et al.
Published: (2013)

Dagligt liv efter besked om icke kurativ lungcancer
by: Carlens, AnnaMi, et al.
Published: (2016)

Patienters erfarenheter av palliativ vård vid lungcancer
by: Persson, Filip, et al.
Published: (2021)

Verotoxin-1 Treatment or Manipulation of its Receptor Globotriaosylceramide (Gb3) for Reversal of Multidrug Resistance to Cancer Chemotherapy
by: Kjell Grankvist, et al.
Published: (2010-10-01)

Faktorer som påverkar livskvaliteten hos personer med lungcancer : En litteraturöversikt
by: Eriksson, Jenny, et al.
Published: (2018)

Fysisk aktivitet som symtomlindring hos patienter med lungcancer : En litteraturstudie
by: Granberg, Johanna, et al.
Published: (2020)

Patienter med lungcancer och deras upplevelser
by: Karlsson, Annika, et al.
Published: (2010)

Le récepteur Gb3/CD77 : analyse de l’apoptose induite par la vérotoxine-1 dans les cellules de lymphome de Burkitt et recherche de ligands endogènes
by: Debernardi, Justine
Published: (2015)

Upplevelsen av hopp hos personer med lungcancer : - En litteraturöversikt
by: Anarp, Sofia, et al.
Published: (2019)

Expression of Globotriaosylceramide in Human CD4+ T-cells
by: Kim, Minji
Published: (2011)

Expression of Globotriaosylceramide in Human CD4+ T-cells
by: Kim, Minji
Published: (2011)

Hälsa och livskvalitet hos personer diagnostiserade med lungcancer : En deskriptiv enkätstudie
by: Lithberg, Malin
Published: (2014)

Att leva med lungcancer : Ur ett patientperspektiv
by: Karlsson, Victoria, et al.
Published: (2011)

Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titres
by: Aizeddin A. Mhanni, et al.
Published: (2020-09-01)

Pathologic substrate of gastropathy in Anderson-Fabry disease
by: Alessandro Di Toro, et al.
Published: (2020-06-01)

Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients
by: Kazuya Tsuboi, et al.
Published: (2017-06-01)

Att leva med lungcancer i den palliativa fasen
by: Borgqvist, Camilla, et al.
Published: (2011)

Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
by: Karl Johansson, et al.
Published: (2020-05-01)

In vitro effect of globotriaosylceramide on electron transport chain complexes and redox parameters
by: RAFAELA M. ALVARIZ, et al.

Targeting Gb3 and apoptosis-related proteins to overcome cisplatin resistance
by: Tyler, Andreas
Published: (2016)

Structural Diversities of Lectins Binding to the Glycosphingolipid Gb3
by: Lina Siukstaite, et al.
Published: (2021-07-01)

Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions
by: Ken Kok, et al.
Published: (2021-02-01)

Faktorer som påverkar hur patienter med lungcancer upplever sin smärta och mötet med sjuksköterskan
by: Ahmetaj, Zana, et al.
Published: (2009)

Characterisation and treatment of a mouse model of Fabry disease
by: Heare, Tanya
Published: (2003)

Bacterial toxins for cancer treatment
by: Johansson, David
Published: (2008)

The importance og LRIG1 in lung cancer
by: Kvarnbrink, Samuel
Published: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p8v6r8td5nv1qt6gcupalso834